• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Comparison between low-molecular and unfractionated heparin in the prevention of thrombosis in patients with total endoprosthetic replacement of hip and knee joint].

作者信息

Rader C P, Kramer C, König A, Gohlke F, Eulert J

机构信息

Orthopädische Universitätsklinik Würzburg.

出版信息

Z Orthop Ihre Grenzgeb. 1997 Jan-Feb;135(1):52-7. doi: 10.1055/s-2008-1039555.

DOI:10.1055/s-2008-1039555
PMID:9199074
Abstract

PURPOSE

Thrombosis-prophylaxies with heparins after total hip arthroplasty (THP) and total knee arthroplasty (TKA) is well accepted. The aim of this study was to compare the low molecular weight heparin (Enoxaparin) with PTT adjusted unfractionated heparin (Na-heparin).

METHODS

In a prospective study of 226 patients after THA and TKA, we performed physical examination and ultrasound in compression and duplex technique one day before surgery and at the 7th and 14th day after surgery. 120 patients received Enoxaparin 1 x 40 mg per day in fixed dosage. 106 patients received Na-heparin 3 x 5000 IE. Since PTT did not reach 40 seconds, Na-heparin dosage was increased to 3 x 7500 IE.

RESULTS

The overall thrombosis rate was 4% (n = 9), in the Enoxaparin group 2.9% for the 70 THA and 10% for the 50 TKA. Thrombosis occurred in the group of unfractionated heparin (PTT adjusted) in 1.8% after THA and in 2% after TKA. In TKA, there is statistical difference between the two heparin groups.

CONCLUSION

In the thrombosis prophylaxis of TKA, PTT adjusted unfractionated heparin is superior to low molecular weight heparin in fixed dosage.

摘要

相似文献

1
[Comparison between low-molecular and unfractionated heparin in the prevention of thrombosis in patients with total endoprosthetic replacement of hip and knee joint].
Z Orthop Ihre Grenzgeb. 1997 Jan-Feb;135(1):52-7. doi: 10.1055/s-2008-1039555.
2
Low-molecular-weight heparin and partial thromboplastin time-adjusted unfractionated heparin in thromboprophylaxis after total knee and total hip arthroplasty.全膝关节置换术和全髋关节置换术后预防血栓形成中低分子量肝素与部分凝血活酶时间调整的普通肝素的比较
J Arthroplasty. 1998 Feb;13(2):180-5. doi: 10.1016/s0883-5403(98)90096-1.
3
Efficacy and safety of enoxaparin to prevent deep vein thrombosis after hip arthroplasty.依诺肝素预防髋关节置换术后深静脉血栓形成的疗效与安全性。
Clin Orthop Relat Res. 1995 Oct(319):215-22.
4
[Experiences with an ankle joint motion device in prevention of thrombosis in patients after total endoprosthesis knee replacement].
Z Orthop Ihre Grenzgeb. 1998 Sep-Oct;136(5):467-70. doi: 10.1055/s-2008-1053686.
5
Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep venous thrombosis after elective knee arthroplasty. Enoxaparin Clinical Trial Group.依诺肝素与普通肝素预防择期膝关节置换术后深静脉血栓形成的疗效和安全性。依诺肝素临床试验组。
Clin Orthop Relat Res. 1995 Dec(321):19-27.
6
The effect of enoxaparin in prevention of deep venous thrombosis in hip and knee surgery--a comparison with the dihydroergotamine-heparin combination.依诺肝素在髋膝关节手术中预防深静脉血栓形成的效果——与双氢麦角胺-肝素联合用药的比较
Ann Chir Gynaecol. 1996;85(4):359-63.
7
Subcutaneous low-molecular-weight heparin vs warfarin for prophylaxis of deep vein thrombosis after hip or knee implantation. An economic perspective.皮下注射低分子量肝素与华法林预防髋或膝关节置换术后深静脉血栓形成的经济学视角
Arch Intern Med. 1997 Feb 10;157(3):298-303.
8
Postoperative anticoagulation in vascular surgery: part 1. A retrospective comparison of clinical outcomes for unfractionated heparin versus low-molecular-weight heparin.血管外科术后抗凝治疗:第1部分。普通肝素与低分子肝素临床结局的回顾性比较。
J Vasc Nurs. 2001 Jun;19(2):42-9; quiz 50-1. doi: 10.1067/mvn.2001.115784.
9
Preventing DVT following total knee replacement: a review of recent clinical trials.
Orthopedics. 1995 Jul;18 Suppl:10-1.
10
Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis.延长依诺肝素治疗以预防初次髋关节或膝关节置换术后静脉血栓栓塞。一项成本效益分析。
Arch Orthop Trauma Surg. 2004 Oct;124(8):507-17. doi: 10.1007/s00402-004-0720-3. Epub 2004 Sep 10.

引用本文的文献

1
[Transient osteoporosis and osteonecrosis of the femoral head. Risk factors, classification and differential diagnosis].[股骨头短暂性骨质疏松和骨坏死。危险因素、分类及鉴别诊断]
Orthopade. 2007 May;36(5):423-4, 426-9. doi: 10.1007/s00132-007-1082-7.